December 18, 2008
Oscient Pharmaceuticals has announced that Dominick Colangelo, executive vice president, corporate development & operations, will resign his current position, effective immediately. Colangelo will stay on with the company as a consultant until Jan. 31, 2009. The resultant corporate team at Oscient will consist of Steve Rauscher, CEO and president, Philippe Maitre, EVP and chief financial officer, and Mark Glickman, SVP, sales and marketing.
Neogenix Oncology has announced the appointment of Ted Sorensen as vice chairman. Sorensen is currently a counsel member as US law firm Paul, Weiss, Fifkind, Wharton & Garrison, and was formerly special counsel and adviser to President John F. Kennedy.